Use of contrast material improves aortic valve assessment during echocardiography: a study

Published Date: 10 Mar 2023

United States: The US research team recommended using a different agent to enhance the Doppler profile for more accurate measurements.

Read Full News

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

How Anesthesiologists Predict Who Will Throw Up After Surgery

— And how we prevent it

Dexamethasone, Ondansetron Show No Difference After Cesarean

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish Experts Expand Care After Perinatal Loss

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Acetaminophen and Autism: Data, Debate, and Risk

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

Palliative Care Use in Hospitalized Hematologic Malignancies

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

Todays Updates

ADHERE REAL Study to Assess Real-World Effectiveness of Efgartigimod in CIDP Isabella Ciccone, MPH

A new study will follow adults with chronic inflammatory demyelinating polyradiculoneuropathy who start subcutaneous efgartigimod in routine practice in the US and Germany.

FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS Isabella Ciccone, MPH

The FDA accepted fenebrutinib's new drug application under priority review for relapsing and primary progressive MS, based on 3 phase 3 trials comparing the BTK inhibitor with teriflunomide and ocrelizumab.

Episode 176: BBP-418 and the Changing Treatment Landscape of LGMD Marco Meglio, Katherine Mathews, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Katherine Matthews, MD. [LISTEN TIME: 17 minutes]

Single Infusion of Rese-Cel Yields Meaningful Responses Off Immunomodulators in Phase 1/2 RESET-MG Trial Isabella Ciccone, MPH

Findings from the phase 1/2 RESET-MG trial, presented at AANEM 2026, showed that 10 of 13 patients with refractory generalized myasthenia gravis had clinically meaningful MG-ADL improvements after a single infusion of rese-cel.

Vanda to Pursue sNDA for Tasimelteon in Delayed Sleep-Wake Phase Disorder After Positive Phase 3 Readout Isabella Ciccone, MPH

In a pivotal phase 3 study, once-daily tasimelteon 20 mg shifted sleep onset 37.1 minutes earlier than placebo in adults with delayed sleep-wake phase disorder.

PETUNIA Study to Track Nipocalimab Use in Pregnancy Marco Meglio

PETUNIA, a new global pharmacovigilance study, will track pregnancy, maternal, and infant outcomes among patients with gMG exposed to nipocalimab.

Insulin Icodec Dosing Strategies for Type 2 Diabetes Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Natalie Bellini, DNP, FNP, BC-ADM, CDCES

In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the commercial release of insulin icodec.

Todays Updates

ADHERE REAL Study to Assess Real-World Effectiveness of Efgartigimod in CIDP Isabella Ciccone, MPH

A new study will follow adults with chronic inflammatory demyelinating polyradiculoneuropathy who start subcutaneous efgartigimod in routine practice in the US and Germany.

FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS Isabella Ciccone, MPH

The FDA accepted fenebrutinib's new drug application under priority review for relapsing and primary progressive MS, based on 3 phase 3 trials comparing the BTK inhibitor with teriflunomide and ocrelizumab.

Episode 176: BBP-418 and the Changing Treatment Landscape of LGMD Marco Meglio, Katherine Mathews, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Katherine Matthews, MD. [LISTEN TIME: 17 minutes]

Single Infusion of Rese-Cel Yields Meaningful Responses Off Immunomodulators in Phase 1/2 RESET-MG Trial Isabella Ciccone, MPH

Findings from the phase 1/2 RESET-MG trial, presented at AANEM 2026, showed that 10 of 13 patients with refractory generalized myasthenia gravis had clinically meaningful MG-ADL improvements after a single infusion of rese-cel.

Vanda to Pursue sNDA for Tasimelteon in Delayed Sleep-Wake Phase Disorder After Positive Phase 3 Readout Isabella Ciccone, MPH

In a pivotal phase 3 study, once-daily tasimelteon 20 mg shifted sleep onset 37.1 minutes earlier than placebo in adults with delayed sleep-wake phase disorder.

PETUNIA Study to Track Nipocalimab Use in Pregnancy Marco Meglio

PETUNIA, a new global pharmacovigilance study, will track pregnancy, maternal, and infant outcomes among patients with gMG exposed to nipocalimab.

Insulin Icodec Dosing Strategies for Type 2 Diabetes Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Natalie Bellini, DNP, FNP, BC-ADM, CDCES

In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the commercial release of insulin icodec.

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

— And how we prevent it

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

News All Time

Coma Therapy Tied to Poor Outcomes in Nonconvulsive SE

Patients with nonconvulsive status epilepticus treated with therapeutic coma experience markedly higher rates of complications and mortality than those not receiving the treatment.

Whole Person Approach to Pain Management for Vets in Hospice

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Axial PsA Diagnosis: Applying AXIS Evidence in Practice

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

Doc Sues Malpractice Insurer for Refusing to Settle Lawsuit

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

Cancer Pain Remains a Major Clinical Challenge

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

Outpatient Palliative Care Consult and End-of-Life Outcomes

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

French Experts Say Medical Hypnosis May Ease ENT Procedures

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

Inpatient Palliative Care in Gynecological Malignancies

This study evaluated the national prevalence, trends, and inpatient outcomes of palliative care use among women hospitalized with gynecological malignancies.

Half of Veterans With Stage IV Cancer Die Without Hospice

Hospice care improves symptom control, reduces ICU utilization, and raises family-rated quality of dying among patients with advanced cancer.

Disposables Dominate Cesarean Anesthesia Carbon Footprint

Disposable items account for the majority of anesthesia-related carbon emissions during cesarean delivery, with a notable portion coming from products that are opened but discarded without use.

Trust Is Earned, Not Assumed

Trust flows both ways between physicians and their patients, says John Whyte, MD, MPH, CEO and executive vice president of the American Medical Association. Dr Whyte shares how he seeks to build that trust.

Hallucinogens: Overhyped and Underwhelming

Enthusiasm for hallucinogens has surged, but has the evidence kept pace? Dr Nassir Ghaemi examines the research behind ketamine, psilocybin, and MDMA — and argues for a more critical look.

Medicine Is a Team Sport

John Whyte, MD, MPH, CEO and executive vice president of the AMA, shares his advice for new physicians on how to build trust with their patients.

Poor Function Before ICU Admission Tied to Later Death Risk

Frailty and functional dependency before admission are associated with an increased risk for mortality after admission to the ICU, although the evidence remains uncertain.

Social Egg Freezing: Choice, Business, or Burden?

Growing interest in egg preservation raises questions about access, affordability, informed consent, and whether workplace pressures shift reproductive responsibility onto women.

Booming Weight-loss Drug Demand in Brazil Fuels Thriving Black Market and Health Fears

When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the...

Recommended News For You

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Recommended Articles For You

Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options 

Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition 

Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies 

Exploring the Role of Fecal Leukocytes in Intestinal Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A computer-aided diagnostic system for improved detection of breast cancer.

2.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

3.

Oncology Drug Shortages Persist, but Continue to Evolve

4.

Kate Middleton Announces Major Cancer Update

5.

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

1.

RNA Immunotherapy for Solid Tumors: Mechanisms, Advances, and Clinical Implications

2.

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends

3.

Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms 

4.

Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy

5.

Everything You Need to Know About HTLV: A Comprehensive Guide 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Navigating the Complexities of Ph Negative ALL - Part XIV

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

4.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot